{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:23:05Z","timestamp":1792110185458,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Mu601\/17-1"],"award-info":[{"award-number":["Mu601\/17-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biochi.2016.10.019","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T04:47:51Z","timestamp":1480654071000},"page":"90-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["PPAR\u03b2\/\u03b4 in human cancer"],"prefix":"10.1016","volume":"136","author":[{"given":"Rolf","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2016.10.019_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00025.2005","article-title":"Transcriptional regulation of metabolism","volume":"86","author":"Desvergne","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biochi.2016.10.019_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biochi.2016.10.019_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tem.2015.09.004","article-title":"Establishing the role of PPARbeta\/delta in carcinogenesis","volume":"26","author":"Peters","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.lfs.2013.10.022","article-title":"Harnessing the benefits of PPARbeta\/delta agonists","volume":"93","author":"Mackenzie","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.biochi.2016.10.019_bib6","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1128\/MCB.20.14.5119-5128.2000","article-title":"Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)","volume":"20","author":"Peters","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.10.019_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1083\/jcb.200809028","article-title":"Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta\/delta is essential for skin homeostasis and wound healing","volume":"184","author":"Chong","year":"2009","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.biochi.2016.10.019_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cmet.2008.04.002","article-title":"Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity","volume":"7","author":"Kang","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","article-title":"Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance","volume":"7","author":"Odegaard","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2567.2010.03261.x","article-title":"Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis","volume":"130","author":"Kanakasabai","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.biochi.2016.10.019_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1523-1747.2003.12536.x","article-title":"Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin","volume":"121","author":"Westergaard","year":"2003","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.biochi.2016.10.019_bib12","doi-asserted-by":"crossref","first-page":"e9701","DOI":"10.1371\/journal.pone.0009701","article-title":"Activation of PPARbeta\/delta causes a psoriasis-like skin disease in\u00a0vivo","volume":"5","author":"Romanowska","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.10.019_bib13","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1093\/nar\/gkv331","article-title":"The transcriptional PPAR\u03b2\/\u03b4 network in human macrophages defines a unique agonist-induced activation state","volume":"43","author":"Adhikary","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib14","doi-asserted-by":"crossref","first-page":"e16344","DOI":"10.1371\/journal.pone.0016344","article-title":"Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta)","volume":"6","author":"Adhikary","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.10.019_bib15","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/onc.2012.549","article-title":"Inverse PPARbeta\/delta agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion","volume":"32","author":"Adhikary","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.biochi.2016.10.019_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(01)01589-8","article-title":"PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells","volume":"435","author":"Rival","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cardiores.2004.11.011","article-title":"Peroxisome proliferator-activated receptor beta\/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes","volume":"65","author":"Planavila","year":"2005","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.yjmcc.2006.03.422","article-title":"PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes","volume":"40","author":"Ding","year":"2006","journal-title":"J.\u00a0Mol. Cell Cardiol."},{"key":"10.1016\/j.biochi.2016.10.019_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1087344","article-title":"Transcriptional repression of atherogenic inflammation: modulation by PPARdelta","volume":"302","author":"Lee","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.biochi.2016.10.019_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1097-2765(00)80467-0","article-title":"Molecular recognition of fatty acids by peroxisome proliferator-activated receptors","volume":"3","author":"Xu","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biochi.2016.10.019_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.2910580314","article-title":"Fibroblast activation protein: purification, epitope mapping and induction by growth factors","volume":"58","author":"Rettig","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biochi.2016.10.019_bib22","doi-asserted-by":"crossref","first-page":"13416","DOI":"10.18632\/oncotarget.3826","article-title":"Deregulation of PPAR\u03b2\/\u03b4 target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment","volume":"6","author":"Schumann","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biochi.2016.10.019_bib23","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1101\/gad.13.12.1561","article-title":"Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta","volume":"13","author":"Lim","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.biochi.2016.10.019_bib24","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1073\/pnas.97.24.13275","article-title":"Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer","volume":"97","author":"Gupta","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.10.019_bib25","doi-asserted-by":"crossref","first-page":"46260","DOI":"10.1074\/jbc.M107180200","article-title":"Prostacyclin-dependent apoptosis mediated by PPAR delta","volume":"276","author":"Hatae","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/mol.109.060541","article-title":"15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor \u03b2\/\u03b4 agonist","volume":"77","author":"Naruhn","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","article-title":"Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors","volume":"129","author":"Schug","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.10.019_bib28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1124\/mol.108.050609","article-title":"Ligand activation of peroxisome proliferator-activated receptor-beta\/delta inhibits cell proliferation in human HaCaT keratinocytes","volume":"74","author":"Borland","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1124\/mol.108.050625","article-title":"Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta\/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid","volume":"74","author":"Rieck","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/mol.110.065508","article-title":"Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta\/delta antagonist GSK3787","volume":"78","author":"Palkar","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib31","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.4161\/cbt.8.13.8691","article-title":"A\u00a0novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells","volume":"8","author":"Zaveri","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biochi.2016.10.019_bib32","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/jm900464j","article-title":"Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist","volume":"53","author":"Shearer","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/mol.111.074039","article-title":"High-affinity peroxisome proliferator-activated receptor beta\/delta-specific ligands with pure antagonistic or inverse agonistic properties","volume":"80","author":"Naruhn","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cmdc.201100408","article-title":"Development of improved PPARbeta\/delta inhibitors","volume":"7","author":"Toth","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biochi.2016.10.019_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.114.094672","article-title":"The inverse agonist DG172 triggers a PPARbeta\/delta-independent myeloid lineage shift and promotes GM-CSF\/IL-4-induced dendritic cell differentiation","volume":"87","author":"Lieber","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.10.019_bib36","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/jm2017122","article-title":"(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARbeta\/delta-selective ligand with inverse agonistic properties","volume":"55","author":"Lieber","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.biochi.2016.10.019_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cmdc.201500594","article-title":"Design and synthesis of highly active peroxisome proliferator-activated receptor (PPAR) beta\/delta inverse agonists with prolonged cellular activity","volume":"11","author":"Toth","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biochi.2016.10.019_bib38","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2016.10.019_bib39","doi-asserted-by":"crossref","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer","volume":"8","author":"Gyorffy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.10.019_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Gyorffy","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biochi.2016.10.019_bib41","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/sj.emboj.7600437","article-title":"Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta\/delta expression","volume":"23","author":"Tan","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.biochi.2016.10.019_bib42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","article-title":"The fasting-induced adipose factor\/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity","volume":"281","author":"Mandard","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib43","doi-asserted-by":"crossref","first-page":"29469","DOI":"10.1074\/jbc.M110.142018","article-title":"Transcriptional profiling identifies functional interactions of TGF\u03b2 and PPAR\u03b2\/\u03b4 signaling: synergistic induction of ANGPTL4 transcription","volume":"285","author":"Kaddatz","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmb.2007.06.091","article-title":"Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor \u03b2\/\u03b4","volume":"372","author":"Degenhardt","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2016.10.019_bib45","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1194\/jlr.M400138-JLR200","article-title":"Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4","volume":"45","author":"Ge","year":"2004","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","article-title":"Emerging roles of angiopoietin-like 4 in human cancer","volume":"10","author":"Tan","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.10.019_bib48","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1182\/blood-2011-01-328716","article-title":"ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters","volume":"118","author":"Huang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biochi.2016.10.019_bib49","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2353\/ajpath.2010.100129","article-title":"Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration","volume":"177","author":"Goh","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biochi.2016.10.019_bib50","first-page":"1541","article-title":"Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines","volume":"27","author":"Huang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biochi.2016.10.019_bib51","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/hep.24479","article-title":"HIF-1alpha-activated ANGPTL4 contributes to tumor metastasis via VCAM-1\/integrin beta1 signaling in human hepatocellular carcinoma","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.10.019_bib52","doi-asserted-by":"crossref","first-page":"E1056","DOI":"10.1152\/ajpendo.90345.2008","article-title":"Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production","volume":"295","author":"Gealekman","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib53","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0002-9440(10)64285-X","article-title":"Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma","volume":"162","author":"Le Jan","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biochi.2016.10.019_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2011.01.018","article-title":"Angiopoietin-like 4 protein elevates the prosurvival intracellular O(2)(-):H(2)O(2) ratio and confers anoikis resistance to tumors","volume":"19","author":"Zhu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biochi.2016.10.019_bib55","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCRESAHA.110.217380","article-title":"Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta\/delta and protects against fatty acid-induced oxidative stress","volume":"106","author":"Georgiadi","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib56","doi-asserted-by":"crossref","first-page":"e10421","DOI":"10.1371\/journal.pone.0010421","article-title":"Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma","volume":"5","author":"Verine","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.10.019_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/or_00000897","article-title":"Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion","volume":"24","author":"Nakayama","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biochi.2016.10.019_bib58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/or.2011.1176","article-title":"Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis","volume":"25","author":"Nakayama","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biochi.2016.10.019_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1741-7015-7-9","article-title":"A\u00a0compact VEGF signature associated with distant metastases and poor outcomes","volume":"7","author":"Hu","year":"2009","journal-title":"BMC Med."},{"key":"10.1016\/j.biochi.2016.10.019_bib60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ajpath.2010.10.040","article-title":"Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer","volume":"178","author":"Mannelqvist","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biochi.2016.10.019_bib61","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1006\/jmcc.2002.2021","article-title":"Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha","volume":"34","author":"Belanger","year":"2002","journal-title":"J.\u00a0Mol. Cell Cardiol."},{"key":"10.1016\/j.biochi.2016.10.019_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4093\/dmj.2012.36.5.328","article-title":"Transcriptional regulation of pyruvate dehydrogenase kinase","volume":"36","author":"Jeong","year":"2012","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.biochi.2016.10.019_bib63","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1101\/gad.16771811","article-title":"Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation","volume":"25","author":"Grassian","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.biochi.2016.10.019_bib64","article-title":"The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis","author":"Li","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.biochi.2016.10.019_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2049-3002-2-20","article-title":"Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells","volume":"2","author":"Sun","year":"2014","journal-title":"Cancer Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biochi.2016.10.019_bib67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.plipres.2013.08.005","article-title":"Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids","volume":"52","author":"Zaidi","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","article-title":"Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA","volume":"21","author":"Tan","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2016.10.019_bib69","doi-asserted-by":"crossref","first-page":"17405","DOI":"10.1074\/jbc.M116.713735","article-title":"Transforming growth factor beta mediates drug resistance by regulating the expression of pyruvate dehydrogenase kinase 4 in colorectal cancer","volume":"291","author":"Zhang","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib70","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M114.584821","article-title":"PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade","volume":"289","author":"Liu","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib71","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(02)00646-9","article-title":"Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway","volume":"10","author":"Di-Poi","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biochi.2016.10.019_bib72","doi-asserted-by":"crossref","first-page":"6042162","DOI":"10.1155\/2016\/6042162","article-title":"PPARgene: a database of experimentally verified and computationally predicted PPAR target genes","volume":"2016","author":"Fang","year":"2016","journal-title":"PPAR Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib73","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1038\/oncsis.2016.41","article-title":"PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions","volume":"5","author":"Wang","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.biochi.2016.10.019_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/nar\/gkq773","article-title":"Reverse crosstalk of TGF\u03b2 and PPAR\u03b2\/\u03b4 signaling identified by transcriptional profiling","volume":"39","author":"Stockert","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/1471-2164-13-665","article-title":"Analysis of the peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) cistrome reveals novel co-regulatory role of ATF4","volume":"13","author":"Khozoie","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.biochi.2016.10.019_bib76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/emmm.201302666","article-title":"Src is activated by the nuclear receptor peroxisome proliferator-activated receptor beta\/delta in ultraviolet radiation-induced skin cancer","volume":"6","author":"Montagner","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biochi.2016.10.019_bib77","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.1074\/jbc.M113.514646","article-title":"Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor beta\/delta (FABP5-PPARbeta\/delta) signaling pathway","volume":"289","author":"Armstrong","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib78","doi-asserted-by":"crossref","first-page":"19106","DOI":"10.1074\/jbc.M109.099770","article-title":"Fatty acid-binding protein 5 and PPARbeta\/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth","volume":"285","author":"Kannan-Thulasiraman","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.10.019_bib79","doi-asserted-by":"crossref","first-page":"e16215","DOI":"10.1371\/journal.pone.0016215","article-title":"PPARdelta activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis","volume":"6","author":"Pollock","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.10.019_bib80","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tox.2007.10.023","article-title":"Peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines","volume":"243","author":"Girroir","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.biochi.2016.10.019_bib81","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1535-7163.MCT-13-0836","article-title":"Activation of peroxisome proliferator-activated receptor-beta\/delta (PPAR-beta\/delta) inhibits human breast cancer cell line tumorigenicity","volume":"13","author":"Yao","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biochi.2016.10.019_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40495-015-0026-x","article-title":"Targeting peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) for cancer chemoprevention","volume":"1","author":"Peters","year":"2015","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.biochi.2016.10.019_bib83","doi-asserted-by":"crossref","first-page":"e46009","DOI":"10.1371\/journal.pone.0046009","article-title":"Of PPARbeta\/delta in non-small cell lung cancer","volume":"7","author":"Genini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.10.019_bib84","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1165\/rcmb.2007-0426OC","article-title":"Peroxisome proliferator-activated receptor beta\/delta expression and activation in lung cancer","volume":"39","author":"Pedchenko","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biochi.2016.10.019_bib85","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2008.09.023","article-title":"Effect of ligand activation of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) in human lung cancer cell lines","volume":"254","author":"He","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.biochi.2016.10.019_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature17173","article-title":"High-fat diet enhances stemness and tumorigenicity of intestinal progenitors","volume":"531","author":"Beyaz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2016.10.019_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju052","article-title":"Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-delta\/beta overexpression","volume":"106","author":"Zuo","year":"2014","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.biochi.2016.10.019_bib88","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/jnci\/djp078","article-title":"Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis","volume":"101","author":"Zuo","year":"2009","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.biochi.2016.10.019_bib89","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1038\/sj.onc.1208143","article-title":"PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine","volume":"23","author":"Reed","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.biochi.2016.10.019_bib90","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07202","article-title":"Integration of metabolism and inflammation by lipid-activated nuclear receptors","volume":"454","author":"Bensinger","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2016.10.019_bib91","doi-asserted-by":"crossref","first-page":"18708","DOI":"10.1073\/pnas.1111840108","article-title":"Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance","volume":"108","author":"Gillet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.10.019_bib92","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.biochi.2016.10.019_bib93","first-page":"114","article-title":"Lost in translation: animal models and clinical trials in cancer treatment","volume":"6","author":"Mak","year":"2014","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biochi.2016.10.019_bib94","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1038\/sj.emboj.7601803","article-title":"Deregulation of tumor angiogenesis and blockade of tumor growth in PPAR\u03b2-deficient mice","volume":"26","author":"M\u00fcller-Br\u00fcsselbach","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.biochi.2016.10.019_bib95","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1073\/pnas.0705505104","article-title":"Transcriptional network governing the angiogenic switch in human pancreatic cancer","volume":"104","author":"Abdollahi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.10.019_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2015.02.024","article-title":"M-CSF from cancer cells induces fatty acid synthase and PPARbeta\/delta activation in tumor myeloid cells, leading to tumor progression","author":"Park","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.biochi.2016.10.019_bib97","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ccr.2007.06.013","article-title":"Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes","volume":"12","author":"Ince","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biochi.2016.10.019_bib98","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1038\/ncomms8419","article-title":"Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours","volume":"6","author":"Ince","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biochi.2016.10.019_bib99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12967-016-0816-x","article-title":"Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity","volume":"14","author":"Roscilli","year":"2016","journal-title":"J.\u00a0Transl. Med."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416301936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416301936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T18:56:20Z","timestamp":1655751380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908416301936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":99,"alternative-id":["S0300908416301936"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2016.10.019","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b2\/\u03b4 in human cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2016.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}